Intercept Pharma's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Intercept Pharma is scheduled to report earnings on February 29, 2024, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 88.79M	$ 83.72M	$ 67.96M	$ 77.22M	$ 77.59M
Gross Profit	$ 88.59M	$ 83.72M	$ 67.74M	$ 77.19M	$ 77.16M
EBIT	$ 11.56M	$ -3.01M	$ -29.07M	$ -14.56M	$ -99.49M
EBITDA	$ 11.91M	$ -2.55M	$ -28.61M	$ -14.46M	$ -99.41M
Net Income Common Stockholders	$ 9.76M	$ -5.83M	$ -31.88M	$ -20.82M	$ 267.45M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 322.71M	$ 414.99M	$ 63.02M	$ 485.57M	$ 490.85M
Total Assets	$ 393.16M	$ 484.63M	$ 504.08M	$ 553.71M	$ 559.40M
Total Debt	$ 223.86M	$ 333.41M	$ 705.23M	$ 332.67M	$ 332.31M
Net Debt	$ -98.86M	$ -81.58M	$ 642.21M	$ -152.89M	$ -158.54M
Total Liabilities	$ 321.32M	$ 417.09M	$ 436.90M	$ 460.63M	$ 451.73M
Stockholders Equity	$ 71.84M	$ 67.55M	$ 67.19M	$ 93.08M	$ 107.68M
Cash Flow	-
Free Cash Flow	$ 16.67M	$ -23.40M	$ -51.60M	$ -4.51M	$ -16.92M
Operating Cash Flow	$ 16.69M	$ -23.30M	$ -51.60M	$ -4.81M	$ -16.59M
Investing Cash Flow	$ 59.77M	$ 96.95M	$ 59.32M	$ -54.94M	$ 331.58M
Financing Cash Flow	$ -110.00M	$ -43.00K	$ -254.00K	$ -5.67M	$ -257.40M

Currency in USD

Intercept Pharma Earnings and Revenue History

Income Statement >

Intercept Pharma Debt to Assets

Balance Sheet >

Intercept Pharma Cash Flow

Cash Flow >

Intercept Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing